Latest News and Press Releases

SEATTLE, WA--(Marketwired - May 3, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will host a conference call on Thursday May 5, 2016 at 4:30 pm eastern time to review First...

SEATTLE, WA--(Marketwired - Mar 30, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced 2015 financial results and provided an update on recent company developments.  Steve...

SEATTLE, WA--(Marketwired - Mar 25, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will host a conference call on Wednesday, March 30, 2016 at 4:30 pm eastern time to review...

SEATTLE, WA--(Marketwired - Mar 2, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company developing novel pharmaceutical delivery methods to address breast conditions, including cancer,...

SEATTLE, WA--(Marketwired - Dec 17, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company focused on developing locally-administered pharmaceuticals for the treatment of pre-cancerous...

SEATTLE, WA--(Marketwired - Nov 12, 2015) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced third quarter 2015 financial results and provided an update on recent company developments.  ...

SEATTLE, WA--(Marketwired - Nov 10, 2015) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will issue financial results and corporate developments for the Third Quarter ended...

SEATTLE, WA--(Marketwired - Oct 14, 2015) - Atossa Genetics, Inc. (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast...

SEATTLE, WA--(Marketwired - Oct 9, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS) a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast...

SEATTLE, WA--(Marketwired - Sep 25, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast...